Gliclazide and Pneumoperitoneum - a phase IV clinical study of FDA data

Summary:

Pneumoperitoneum is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 60+ old, also take Bactrim, and have Anaemia.

The phase IV clinical study analyzes which people have Pneumoperitoneum when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Pneumoperitoneum?

Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity) is found to be associated with 221 drugs and 373 conditions by eHealthMe. Check the latest studies of Pneumoperitoneum.

On Jul, 13, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 14 people (0.05%) have Pneumoperitoneum.

Could Gliclazide cause Pneumoperitoneum?

Among these 14 people:

What is the gender of people who have Pneumoperitoneum when taking Gliclazide? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Pneumoperitoneum when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

Bactrim: 9 people, 64.29%
Janumet: 7 people, 50.00%
Neurontin: 7 people, 50.00%
Alprazolam: 7 people, 50.00%
Amitriptyline Hydrochloride: 7 people, 50.00%
Apidra: 7 people, 50.00%
Apixaban: 7 people, 50.00%
Dexamethasone: 7 people, 50.00%
Digoxin: 7 people, 50.00%
Famotidine: 7 people, 50.00%

What are other side effects people have besides Pneumoperitoneum? *

Dizziness: 7 people, 50.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 50.00%
Urinary Tract Infection Bacterial: 7 people, 50.00%
Colon Cancer: 7 people, 50.00%
Diverticular Perforation (serious gastrointestinal condition in which the intestine's walls are perforated): 3 people, 21.43%
Weight Decreased: 2 people, 14.29%
Cardiac Arrest: 2 people, 14.29%
Constipation: 2 people, 14.29%
Abdominal Distension: 2 people, 14.29%
Renal Tubular Necrosis (death of kidney tubules): 2 people, 14.29%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 7 people, 50.00%
Stress And Anxiety: 7 people, 50.00%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 7 people, 50.00%
High Blood Pressure: 7 people, 50.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 7 people, 50.00%
Folate Deficiency (lack of folic acid): 7 people, 50.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 50.00%
Arrhythmias (irregular heartbeat): 7 people, 50.00%
Anaemia (lack of blood): 7 people, 50.00%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Pneumoperitoneum?

- Check whether Pneumoperitoneum is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumoperitoneum:

Pneumoperitoneum (221 drugs)

Browse all the conditions that are associated with Pneumoperitoneum:

Pneumoperitoneum (373 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.